Reprise Biomedical

Reprise Biomedical is an innovative biotechnology startup committed to addressing unmet clinical needs with a focus on delivering solutions for healing. Established in 2019 as a spin-off from Miromatrix Medical Inc., the company has taken ownership of the manufacturing, marketing, and distribution for two commercially available products: MiroDerm biologic wound matrix and MiroFlex biologic matrix for soft tissue reinforcement. Reprise Biomedical distinguishes itself through the utilization of proprietary perfusion decellularization technology, paving the way for the development of advanced medical devices. The company's dedication to innovation is exemplified by its latest offering, Miro3D wound matrix, designed to provide a unique three-dimensional solution for deep and tunneling wounds. Based in the United States, Reprise Biomedical is positioned to make significant strides within the medical device industry. This dynamic startup presents an intriguing opportunity for venture capitalists seeking to support pioneering solutions in the field of biotechnology and medical devices.